Merck

FDA Action Alert: Adamas, Mallinckrodt and Merck
BioSpace
Tue, 02/2/21 - 11:02 am
FDA
Adamas Pharmaceuticals
Mallinckrodt
Merck
Gocovri
StrataGraft
Keytruda
triple negative breast cancer
Merck's Keytruda Proves Better Alone in Combination Trial With BMS' Yervoy
BioSpace
Mon, 02/1/21 - 11:12 pm
Merck
Keytruda
Bristol-Myers Squibb
Yervoy
non-small cell lung cancer
WCLC: With Keytruda-Yervoy data, Merck casts doubt on Opdivo's place in lung cancer
Fierce Pharma
Sat, 01/30/21 - 11:32 pm
WCLC
Keytruda
Yervoy
Merck
Bristol-Myers Squibb
Merck earmarks $10 million to improve U.S. maternal health equity
Fierce Pharma
Sat, 01/30/21 - 11:22 pm
Merck
maternal health
philanthropy
FDA Approvals Roundup: Cabenuva, Lupkynis, Verquvo
RAPS.org
Thu, 01/28/21 - 10:49 am
FDA
Cabenuva
HIV
ViiV
Aurinia
Lupkynis
Merck
Verquvo
Judge orders Merck documents on anti-baldness drug Propecia unsealed
Reuters
Tue, 01/26/21 - 11:50 pm
Merck
Propecia
Startup targets orphan kidney disease with former Merck drug
MedCity News
Tue, 01/26/21 - 11:10 am
Vera Therapeutics
Merck
funding
kidney disease
immunoglobin A nephropathy
atacicept
The year immuno-oncology could break into perioperative settings
EP Vantage
Tue, 01/26/21 - 12:00 am
Merck
Keytruda
breast cancer
immuno-oncology
perioperative breast cancer
Merck cans both its COVID-19 vaccines due to weak clinical data
Fierce Biotech
Mon, 01/25/21 - 11:11 am
Merck
vaccines
COVID-19
GSK, German Merck's $4.2B bintrafusp alfa drug a bust, fails to beat king Keytruda in lung cancer
Fierce Biotech
Wed, 01/20/21 - 10:48 am
GSK
Merck KGaA
bintrafusp alfa
clinical trial
Merck
Keytruda
Can Merck and Bayer's newly approved Verquvo stand out in an ever-more-competitive heart failure field?
Fierce Pharma
Wed, 01/20/21 - 10:43 am
Merck
Bayer
FDA
Verquvo
vericiguat
chronic heart failure
Merck comes up short in last-ditch effort to revive $2.54B patent verdict against Gilead
Fierce Pharma
Tue, 01/19/21 - 09:18 pm
Merck
Idenis
Gilead Sciences
patents
Harvoni
Sovaldi
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
Tue, 01/19/21 - 10:30 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
Scientist charged with stealing secrets from Merck
New Jersey Today
Thu, 01/14/21 - 10:49 am
Merck
trade secrets
Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA
Endpoints
Tue, 01/12/21 - 10:59 am
Merck
V114
pneumococcal disease
vaccines
FDA
priority review
Prevnar 13
Pfizer
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China
Fierce Pharma
Wed, 12/30/20 - 10:53 am
Merck
Bristol-Myers Squibb
AstraZeneca
Roche
Keytruda
Opdivo
Imfinzi
Tecentriq
China
PD-1 inhibitors
Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan
Motley Fool
Tue, 12/29/20 - 10:57 am
Merck
AstraZeneca
Japan
ovarian cancer
prostate cancer
pancreatic cancer
Lynparza
Merck signs $356M deal to supply US with experimental coronavirus drug
BioPharma Dive
Sat, 12/26/20 - 08:06 pm
Merck
COVID-19
government contract

Pages